Cargando…

Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis

Vasa previa carries a high risk of severe fetal morbidity and mortality due to fetal hemorrhage caused by damage to unprotected fetal cord vessels upon membrane rupture. Vasa previa is generally classified into types I and II. However, some cases are difficult to classify, and some studies have prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemoto, Yuki, Matsuzaki, Shinya, Matsuzaki, Satoko, Kakuda, Mamoru, Lee, Misooja, Hayashida, Harue, Maeda, Michihide, Kamiura, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856204/
https://www.ncbi.nlm.nih.gov/pubmed/36672661
http://dx.doi.org/10.3390/biomedicines11010152
_version_ 1784873566345363456
author Takemoto, Yuki
Matsuzaki, Shinya
Matsuzaki, Satoko
Kakuda, Mamoru
Lee, Misooja
Hayashida, Harue
Maeda, Michihide
Kamiura, Shoji
author_facet Takemoto, Yuki
Matsuzaki, Shinya
Matsuzaki, Satoko
Kakuda, Mamoru
Lee, Misooja
Hayashida, Harue
Maeda, Michihide
Kamiura, Shoji
author_sort Takemoto, Yuki
collection PubMed
description Vasa previa carries a high risk of severe fetal morbidity and mortality due to fetal hemorrhage caused by damage to unprotected fetal cord vessels upon membrane rupture. Vasa previa is generally classified into types I and II. However, some cases are difficult to classify, and some studies have proposed a type III classification. This study aimed to review the current evidence on type III vasa previa. A systematic literature search was conducted, and 11 articles (2011–2022) were included. A systematic review showed that type III vasa previa accounts for 5.7% of vasa previa cases. Thirteen women with type III vasa previa were examined at a patient-level analysis. The median age was 35 (interquartile range [IQR] 31.5–38) years, and approximately 45% were assisted reproductive technology (ART) pregnancies. The median gestational week of delivery was 36 (IQR 34–37) weeks; the antenatal detection rate was 84.6%, and no cases reported neonatal death. The characteristics and obstetric outcomes (rate of ART, antenatal diagnosis, emergent cesarean delivery, gestational age at delivery, and neonatal mortality) were compared between types I and III vasa previa, and all outcomes of interest were similar. The current evidence on type III vasa previa is scanty, and further studies are warranted.
format Online
Article
Text
id pubmed-9856204
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98562042023-01-21 Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis Takemoto, Yuki Matsuzaki, Shinya Matsuzaki, Satoko Kakuda, Mamoru Lee, Misooja Hayashida, Harue Maeda, Michihide Kamiura, Shoji Biomedicines Systematic Review Vasa previa carries a high risk of severe fetal morbidity and mortality due to fetal hemorrhage caused by damage to unprotected fetal cord vessels upon membrane rupture. Vasa previa is generally classified into types I and II. However, some cases are difficult to classify, and some studies have proposed a type III classification. This study aimed to review the current evidence on type III vasa previa. A systematic literature search was conducted, and 11 articles (2011–2022) were included. A systematic review showed that type III vasa previa accounts for 5.7% of vasa previa cases. Thirteen women with type III vasa previa were examined at a patient-level analysis. The median age was 35 (interquartile range [IQR] 31.5–38) years, and approximately 45% were assisted reproductive technology (ART) pregnancies. The median gestational week of delivery was 36 (IQR 34–37) weeks; the antenatal detection rate was 84.6%, and no cases reported neonatal death. The characteristics and obstetric outcomes (rate of ART, antenatal diagnosis, emergent cesarean delivery, gestational age at delivery, and neonatal mortality) were compared between types I and III vasa previa, and all outcomes of interest were similar. The current evidence on type III vasa previa is scanty, and further studies are warranted. MDPI 2023-01-07 /pmc/articles/PMC9856204/ /pubmed/36672661 http://dx.doi.org/10.3390/biomedicines11010152 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Takemoto, Yuki
Matsuzaki, Shinya
Matsuzaki, Satoko
Kakuda, Mamoru
Lee, Misooja
Hayashida, Harue
Maeda, Michihide
Kamiura, Shoji
Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
title Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
title_full Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
title_fullStr Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
title_full_unstemmed Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
title_short Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
title_sort current evidence on vasa previa without velamentous cord insertion or placental morphological anomalies (type iii vasa previa): systematic review and meta-analysis
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856204/
https://www.ncbi.nlm.nih.gov/pubmed/36672661
http://dx.doi.org/10.3390/biomedicines11010152
work_keys_str_mv AT takemotoyuki currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT matsuzakishinya currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT matsuzakisatoko currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT kakudamamoru currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT leemisooja currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT hayashidaharue currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT maedamichihide currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis
AT kamiurashoji currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis